Category: News
Investigating CAR-T Cell Therapy for Advanced Melanoma
By Renee Orcione, MRA Digital Engagement & Communications Manager | 28 August 2024 In Allies & Partnerships, News, Science, Treatment
One of the greatest scientific breakthroughs in melanoma research has been the FDA approval of cancer immunotherapy treatments called checkpoint inhibitors. These treatments stimulate the body’s own immune system to fight off melanoma. Checkpoint immunotherapies, first approved in melanoma, are now being used to treat a number of different cancer types.
RARE Registry: Providing Hope Through Innovation
26 July 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Each year approximately 5,000 patients are diagnosed with acral or mucosal melanoma. These rare melanoma subtypes arise in non-sun exposed areas and are not believed to be caused by UV damage. Due to the relative obscurity of these rare subtypes, patients face mounting challenges ranging from late diagnoses, lack of support,...
MRA's Latest Research Report: We Are Melanoma Research
19 July 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Each year, the Melanoma Research Alliance brings together melanoma thought leaders from across the global research community to exchange ideas, share recent scientific successes and hurdles, forge new collaborations, and connect with the patient advocate community.
Melanoma Awareness Month 2024: In Case You Missed It
By Renee Orcione, MRA Digital Engagement & Communications Manager | 30 May 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Throughout the last 31 days, the entire melanoma community has come together to recognize Melanoma Awareness Month. The community heard from leading experts in the field, connected with other patient advocates, and spread awareness of melanoma and the importance of prevention, early detection, and the impact of research.
Melanoma Research Alliance Announces $12.6 Million Investment in Cutting Edge Melanoma Research
1 May 2024 In Allies & Partnerships, News, Prevention, Science, Treatment
The Melanoma Research Alliance (MRA), the world’s leading non-profit funder of melanoma research, announced its $12.6 million commitment to fund melanoma research supporting more than 30 scientists at leading academic and medical institutions in the United States and across the globe. Melanoma, the deadliest form of skin cancer, remains a public...
Melanoma Awareness Month: Ways to Get Involved
By Renee Orcione, MRA Digital Engagement & Communications Manager | 29 April 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Melanoma Awareness Month, held each May, is an occasion to connect and be in community with others who have been touched by melanoma. With this month brings the opportunity to join forces with other melanoma advocates to raise awareness of melanoma research, the importance of early detection, and the many...
What Melanoma Patients Need to Know About AMTAGVI
By Renee Orcione, MRA Digital Engagement & Communications Manager | 28 March 2024 In News, Science, Treatment
You may have heard of AMTAGVI, also known by the generic name lifileucel, a new therapy that recently earned FDA approval. AMTAGVI is a type of cellular therapy that uses Tumor Infiltrating Lymphocytes (TILs) to treat patients with advanced melanoma whose melanoma hasn’t responded – or quit responding – to PD-1 based immunotherapies and BRAF/MEK targeted therapy if their melanoma has the BRAF mutation.
The Future of Immunotherapy & Cell-based Therapies
11 March 2024 In Allies & Partnerships, Events, News, Science, Treatment
“Melanoma research helped lead the way to a lot of paradigm shifts in cancer treatment,” says Dr. Antoni Ribas, Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA).
Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma
16 February 2024 In Events, News, Treatment
The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, welcomes the U.S. Food and Drug Administration (FDA) decision to approve Iovance Biotherapeutics’ AMTAGVITM (lifileucel) for the treatment of patients with advanced melanoma in the second line treatment setting.
100,000 Americans Estimated to be Diagnosed with Invasive Melanoma in 2024
By Joan Levy, PhD - MRA Chief Science Officer | 26 January 2024 In News, Prevention, Science, Treatment
Each January, the American Cancer Society (ACS) releases updated estimates about trends in new cancer cases and deaths in its annual report, Cancer Facts and Figures. This report highlights the estimated incidence (number of new cases), prevalence (number of people alive today with a history of cancer), and survival statistics for...